#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma recurrent Mucopolysaccharidosis II Pleomorphic liposarcoma Thalassaemia beta Cerebral arteriovenous malformation haemorrhagic Metastases to central nervous system Encephalitis autoimmune Myocarditis Kearns-Sayre syndrome Malignant fibrous histiocytoma Neuroendocrine carcinoma of the skin Infection in an immunocompromised host Familial dilated cardiomyopathy Paroxysmal nocturnal haemoglobinuria Pleomorphic leiomyosarcoma More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia Advanced systemic mastocytosis – Diagnostics Pulmonary sarcoidosis – Life with Disease Anaplastic thyroid cancer – Trials in Disease Lymphangioma – Basic Information Niemann-Pick disease – Trials in Disease Rhabdomyosarcoma – Life with Disease Hairy cell leukaemia Chronic granulomatous disease – Basic Information Langerhans’ cell histiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oditrasertib Atogepant Dl-Alpha-Tocopherol L-Lysine Acetate A24110He Transpocart19 Testosterone Undecanoate Deucrictibant Lithium Carbonate FLUCLOXACILLIN SODIUM ATUMELNANT Talazoparib Lenalidomide Norfloxacin Polatuzumab Vedotin Amivantamab RNMB2 Vsf1.01 Nifedipine Bp1.7881A More therapies…

    Learn about Your Condition

    Inborn error of metabolism Neurogenic bladder Cold urticaria Colorectal cancer stage IV Aneurysm ruptured Neonatal respiratory failure Hepatobiliary disease Cholangiocarcinoma Influenza Ocular melanoma Usher's syndrome Dry eye Procedural pain Dermatitis Pre-eclampsia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Overweight

  • A study testing maridebart cafraglutide for weight loss in adults with overweight or obesity, with or without type 2 diabetes

    Not recruiting

    2 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Maridebart Cafraglutide
    Czechia Germany Hungary Poland Spain

  • A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    • Obesity
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Enalapril Maleate
    • Cagrilintide
    France Greece Hungary Poland Slovakia Spain

  • A study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    Croatia Czechia Hungary Romania Slovakia

  • Study of cagrilintide for weight reduction in adults with overweight or obesity when combined with lifestyle changes

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    France Germany Italy Norway Poland

  • Study of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Czechia Germany

  • Study on the Effects of RO7204239 and Tirzepatide for Weight Loss in Patients with Obesity or Overweight with a Weight-Related Health Issue

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Human Latent Myostatin
    • Tirzepatide
    Poland Spain
Previous Page
1 2 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!